Tamiflu Still Number One In Treatment Of Bird Flu

by Medindia Content Team on August 25, 2007 at 6:10 PM
Tamiflu Still Number One In Treatment Of Bird Flu

In updated guidance from the World Health Organization, Tamiflu (oseltamivir) remains the primary recommended antiviral of choice in treating patients infected with H5N1. Experts believe that a human influenza pandemic is imminent and could be triggered by the highly pathogenic H5N1 strain, which, as of Aug. 16 2007, has infected 321 humans, causing 194 deaths worldwide.

"Experiences clearly show that to reduce mortality patients should receive treatment with oseltamivir as early as possible, but treatment remains effective even when patients present late," commented Professor John Oxford, Professor of Virology at St Bartholomew's and the Royal London Hospital, "H5N1 has proven to be an extremely virulent virus in humans and in some countries we have seen the need to use higher and longer doses of oseltamivir to gain maximum benefit."


The latest advice is based on evidence presented to the WHO by experts in countries that have reported human cases of bird flu. Tamiflu is the only neuraminidase inhibitor to have been used in the management of human cases of H5N1 and is the only antiviral strongly recommended for treatment of H5N1 infected patients by the WHO.

With this latest evidence WHO recommends:

Standardising care and promptly sharing clinical and treatment information to improve understanding of the disease and identify appropriate therapy.

Tamiflu remaining the primary antiviral treatment both early and late in the infection as there is evidence of prolonged replication with H5N1.

Modified Tamiflu treatment regimens - higher and longer dosing may be necessary given the virulence of some forms of H5N1 seen recently.

Possible combination therapy with adamantanes (case by case basis), particularly in patients with pneumonia or progressive disease.

The guidance also states that inhaled zanamivir has not been studied in human H5N1 illness and that the adequacy of inhaled zanamivir delivery in patients with serious lower respiratory tract or extra pulmonary disease is a major concern. Ongoing modifications will be made to the WHO guidance based on continual research findings.

During the clinical development programme Roche carried out studies looking at higher doses of Tamiflu. The safety profile at these higher doses was supportive of further investigation A high versus standard dosage study has recently started in patients with severe influenza, both H5N1 and seasonal, in conjunction with the National Institutes of Health (NIH), to determine which is the most effective dose in severe disease.

WHO coordinates the global response to human cases of H5N1 avian influenza and tracks the corresponding threat of an influenza pandemic, providing access to both technical guidelines and information useful for the general public.

Tamiflu is an oral neuraminidase inhibitor that is active against all strains of influenza A and B tested. More than 80 governments worldwide are now stockpiling Tamiflu in preparation for a pandemic and many global businesses are in discussions with Roche and are now stockpiling for their employees and their families in line with local laws and regulations.

Source: Eurekalert
Font : A-A+



Recommended Readings

Latest Bird Flu News

Japan Records Second Avian Flu Outbreak of the Season
Japan's Ministry of Agriculture confirmed a new highly pathogenic avian flu case at an Ibaraki poultry farm, marking the country's second outbreak this season.
Gene-Edited Chickens Hold the Key to Combat Bird Flu
Scientists have successfully utilized gene editing techniques to control the transmission of avian influenza among chickens.
Mutational Changes in Bird Flu Virus Signal Potential Pandemic
The study reports documented cases of A (H3N8) avian influenza viruses crossing species boundaries and affecting a range of mammals, including dogs and horses.
Genetic Change Boosts Bird Flu Severity
Researchers monitored the continuing avian flu pandemic to gauge its evolving risk to both humans and birds.
Bird Flu in Brazil: 6-month Health Emergency Declared
Bird flu in Brazil: Authorities are watching if the bird flu virus H5N1 is mutating into a form which can spread amongst humans.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Tamiflu Still Number One In Treatment Of Bird Flu Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests